| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgment of Reviewers
|
|
|
2017
|
92 |
C |
p. 133-135
|
artikel
|
| 2 |
A likelihood-based approach to P-value interpretation provided a novel, plausible, and clinically useful research study metric
|
Adams, Nicholas G.
|
|
2017
|
92 |
C |
p. 111-115
|
artikel
|
| 3 |
A novel statistical model for analyzing data of a systematic review generates optimal cutoff values for fractional exhaled nitric oxide for asthma diagnosis
|
Schneider, Antonius
|
|
2017
|
92 |
C |
p. 69-78
|
artikel
|
| 4 |
A randomized trial found online questionnaires supplemented by postal reminders generated a cost-effective and generalizable sample but don’t forget the reminders
|
Loban, Amanda
|
|
2017
|
92 |
C |
p. 116-125
|
artikel
|
| 5 |
Comparative effectiveness medicines research cannot assess efficacy
|
Dal-Ré, Rafael
|
|
2017
|
92 |
C |
p. 129
|
artikel
|
| 6 |
Controversy and debate on clinical genomics sequencing—paper 2: clinical genome-wide sequencing: don't throw out the baby with the bathwater!
|
Adam, Shelin
|
|
2017
|
92 |
C |
p. 7-10
|
artikel
|
| 7 |
Controversy and debate on clinical genomics sequencing—paper 4: clinical genome-wide sequencing: response to Wilson, Miller, and Rousseau
|
Adam, Shelin
|
|
2017
|
92 |
C |
p. 13-15
|
artikel
|
| 8 |
Controversy and debate on clinical genomics sequencing—paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing
|
Wilson, Brenda J.
|
|
2017
|
92 |
C |
p. 4-6
|
artikel
|
| 9 |
Controversy and debate on clinical genomics sequencing—paper 3: response to “clinical genome-wide sequencing: do not throw out the baby with the bathwater”
|
Wilson, Brenda J.
|
|
2017
|
92 |
C |
p. 11-12
|
artikel
|
| 10 |
David Sackett Young Investigator Award
|
|
|
2017
|
92 |
C |
p. 126-127
|
artikel
|
| 11 |
Decision making about healthcare-related tests and diagnostic test strategies. Paper 1: a new series on testing to improve people's health
|
Schünemann, Holger J.
|
|
2017
|
92 |
C |
p. 16-17
|
artikel
|
| 12 |
Decision making about healthcare-related tests and diagnostic test strategies. Paper 5: a qualitative study with experts suggests that test accuracy data alone is rarely sufficient for decision making
|
Mustafa, Reem A.
|
|
2017
|
92 |
C |
p. 47-57
|
artikel
|
| 13 |
Decision making about healthcare-related tests and diagnostic test strategies. Paper 2: a review of methodological and practical challenges
|
Mustafa, Reem A.
|
|
2017
|
92 |
C |
p. 18-28
|
artikel
|
| 14 |
Decision making about healthcare-related tests and diagnostic test strategies. Paper 3: a systematic review shows limitations in most tools designed to assess quality and develop recommendations
|
Mustafa, Reem A.
|
|
2017
|
92 |
C |
p. 29-37
|
artikel
|
| 15 |
Decision making about healthcare-related tests and diagnostic test strategies. Paper 4: International guidelines show variability in their approaches
|
Mustafa, Reem A.
|
|
2017
|
92 |
C |
p. 38-46
|
artikel
|
| 16 |
Editorial Board
|
|
|
2017
|
92 |
C |
p. IFC
|
artikel
|
| 17 |
Favorable and publicly funded studies are more likely to be published: a systematic review and meta-analysis
|
Canestaro, William J.
|
|
2017
|
92 |
C |
p. 58-68
|
artikel
|
| 18 |
Five indicators were developed to assess the quality of reviews on preventive interventions
|
Allaouat, Sara
|
|
2017
|
92 |
C |
p. 89-98
|
artikel
|
| 19 |
From testing to diagnostic strategies and dia-prognostic research
|
Knottnerus, J. André
|
|
2017
|
92 |
C |
p. 1-3
|
artikel
|
| 20 |
Most systematic reviews of high methodological quality on psoriasis interventions are classified as high risk of bias using ROBIS tool
|
Gómez-García, Francisco
|
|
2017
|
92 |
C |
p. 79-88
|
artikel
|
| 21 |
Reply to: comparative effectiveness medicines research cannot assess efficacy
|
Hester, Laura L.
|
|
2017
|
92 |
C |
p. 130-132
|
artikel
|
| 22 |
Reviewer Award
|
|
|
2017
|
92 |
C |
p. 128
|
artikel
|
| 23 |
Table of Contents
|
|
|
2017
|
92 |
C |
p. iii-v
|
artikel
|
| 24 |
The new measuring multimorbidity index predicted mortality better than Charlson and Elixhauser indices among the general population
|
Stanley, James
|
|
2017
|
92 |
C |
p. 99-110
|
artikel
|
Tijdschrift beschrijving